
RS Investments
North America, California, United States, San Francisco
Description
RS Investments have been delivering better client outcomes through research-driven active strategies
Investor Profile
RS Investments has made 8 investments, with 0 in the past 12 months and 13% as lead.
Stage Focus
- Post Ipo Equity (63%)
- Series B (13%)
- Series E (13%)
- Series A (13%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Clinical Trials
- Home Health Care
- Genetics
- Health Diagnostics
- Life Science
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.